Insider Transactions Reported by 19 Insiders of Acumen Pharmaceuticals, Inc.

Symbol
ABOS on Nasdaq
Location
Newton, MA

Insiders trading volume in the past year

Acumen Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sands Capital Ventures Discovery Fund III, L.P. 10%+ Owner $11,859,300 06 Jul 2021
Paul B. Manning 10%+ Owner $2,283,603 06 Jul 2021
Robert D. Hardie 10%+ Owner $2,283,603 06 Jul 2021
Daniel Joseph OConnell Chief Executive Officer, Director $1,231,284 -$114,278 -8.5% 05 Jan 2026
Matt Zuga CFO & Chief Business Officer $430,685 -$86,056 -17% 05 Jan 2026
Eric Siemers Chief Medical Officer $313,665 -$26,395 -7.8% 05 Jan 2026
Derek Meisner Chief Legal Officer & Corp Sec $267,519 -$58,125 -18% 05 Jan 2026
Russell Barton Chief Operating Officer $251,962 -$23,017 -8.4% 05 Jan 2026
John A. Stalfort III Director $203,636 04 Jun 2025
James J. Doherty President and CDO $98,329 -$15,148 -13% 07 Jan 2026
Nathan B. Fountain Director $20,955 04 Jun 2025
Amy Schacterle Chief Regulatory Officer $15,281 -$2,176 -12% 07 Jan 2026
Laura Stoppel Director $14,080 04 Jun 2025
Jeffrey L. Ives Director $14,080 04 Jun 2025
Kimberlee C. Drapkin Director $14,080 04 Jun 2025
RA CAPITAL MANAGEMENT, L.P. Director, 10%+ Owner $14,080 04 Jun 2025
Derrell Porter Director $14,080 04 Jun 2025
Jeffrey Sevigny Director 15 Jun 2022
George Golumbeski Director 06 Nov 2025

Recent Insider Transactions by Companies or Individuals for Acumen Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.